Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

HFSB adds two big investors on its board and signs up two London hedge funds

Thursday, February 11, 2010
Opalesque Industry Update - The Hedge Fund Standards Board (HFSB) is expanding the role played by investors on its board by adding representatives from two of the biggest international investors in hedge funds, New Holland Capital and the Future Fund, Australia.

The HFSB has also signed up two more of the leading London-based hedge fund managers, BlueCrest Capital Management LLP and Winton Capital Management Ltd. Both will become members of the HFSB Founders’ Council, the core group of managers and investors who launched the project and provide regular advice to the Board.

Virtually all of the largest hedge fund managers in London have now become signatories to the Standards and are therefore committed to applying them.

Antonio Borges, Chairman of the HFSB, said:
“These developments mark a significant step up in the international support for the Standards from both investors and managers.

“The HFSB has taken a decision to expand investor representation and we are delighted to have backing from two more of the biggest global investors in hedge funds to broaden our already significant investor input.

“We are also delighted to have BlueCrest and Winton, two highly regarded players in the London hedge fund scene, signaling their commitment to the Standards.”

The new trustees of the hedge fund standard setter are Tom Dunn, Managing Principal of New Holland Capital and David Neal, Chief Investment Officer of the Future Fund.

New Holland Capital is the hedge fund advisor of the Netherlands-based APG. APG is one of the largest pension asset managers in the world with assets under management of approximately €240bn ($329bn). The Future Fund manages public pension funds for teachers and health workers in Australia.

Tom Dunn, Managing Partner of New Holland Capital, said: “The Standards play an important role in bringing about transparency and best practice among hedge fund managers.” David Neal, CIO of the Future Fund, said: “We are very pleased to be represented and hope to see a growing number of managers embracing the Standards.”

The addition of BlueCrest and Winton bring the number of managers committed to the Hedge Fund Standards to 56, accounting for more than $215bn of assets under management. By comparison, the total AUM in European Hedge Funds was $350bn at end-June 2009, according to EuroHedge.

www.hfsb.org


Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its